Aurubis extends CEO Toralf Haag mandate to Feb. 28, 2031

Aurubis extended CEO Dr. Toralf Haag’s mandate to Feb. 28, 2031, prolonged COO Tim Kurth’s appointment to June 30, 2032, planned a five-year extension for CFO Steffen Alexander Hoffmann through Sept. 30, 2032, and set board and leadership changes including Inge Hofkens stepping down Sept. 30, 2026.